FDA Cleared Platform PinMed's FDA-cleared cloud-based platform enables remote cardiovascular monitoring and longitudinal data analytics. This regulatory clearance is a strong credential when approaching hospitals, cardiology clinics, and clinical research organizations that require compliant, scalable patient monitoring and early detection of subtle CV changes. Emphasize seamless EHR/EMR integration and the ability to shorten study timelines and reduce monitoring costs.

Strategic Partnerships As a lean operation, PinMed can accelerate market reach through co-sell arrangements with larger medical device manufacturers, CROs, and health IT integrators. The demonstrated Navy contract collaboration and National Marine Mammal Foundation partnership highlight capability to work with government, research, and defense programs, opening doors to government and academic opportunities.

CV Endpoint Analytics The analytics capability for detecting subtle, clinically meaningful longitudinal changes in cardiovascular status offers a compelling value proposition for pharma sponsors and CROs running cardiovascular trials, enabling more precise endpoints, improved trial efficiency, and potential cost savings.

OEM Licensing There is opportunity to license or white-label PinMed’s technology to OEMs or telehealth vendors seeking embedded cardiovascular monitoring and analytics in their devices or apps, expanding reach without building a large direct sales force.

Pilot ROI Focus Propose targeted pilots with hospitals or health systems to quantify efficiency gains, reduced testing costs, and faster study iteration, then scale adoption across departments or geographies through proven ROI and peer referrals.